Korean J Anesthesiol.  2000 Aug;39(2):270-274. 10.4097/kjae.2000.39.2.270.

Cardiopulmonary Bypass in Patient with Heparin-Induced Thrombocytopenia Employing Recombinant Hirudin

Affiliations
  • 1Department of Anesthesiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
  • 2Department of Cardiothoracic Surgery, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.

Abstract

Heparin-induced thrombocytopenia (HIT) is a heparin-dependent antibody-mediated platelet activating syndrome frequently accompanying thrombocytopenia, thromboembolism. We experienced a case of cardiopulmonary bypass using hirudin, a direct thrombin inhibitor, in a patient with HIT. The patient who showed thrombocytopenia and thrombosis after heparin re-exposure was highly suspected of having HIT. Hirudin was used in this case as an anticoagulating agent during cardiopulmonary bypass (CPB) to prevent serious complications of heparin. Hirudin 0.3 mg/kg was mixed with a priming solution of CPB and a 0.2 mg/kg IV bolus followed by a continuous infusion of hirudin 0.15 mg/kg given for anticoagulation. After CPB, forced diuresis and platelet transfusion was performed and the patient was recovered without complication.

Keyword

Complications: heparin induced thrombocytopenia; Heart: cardiopulmonary bypass; Hemorrhage: hirudin

MeSH Terms

Blood Platelets
Cardiopulmonary Bypass*
Diuresis
Heparin
Hirudins*
Humans
Platelet Transfusion
Thrombin
Thrombocytopenia*
Thromboembolism
Thrombosis
Heparin
Hirudins
Thrombin
Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr